Skip to content
Home/Companies/MedTech/Decon

Decon

MedTech·Sweden·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Decon?

Decon is a Swedish MedTech company, currently owned by Impilo since 2023.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQSweden
SectorMedTech
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Pelago Bioscience
Active
PharmaSweden· 2023
Stille
Active
MedTechSweden· 2023
VaccinDirekt
Active
HealthcareSweden· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Decon?

Decon is currently owned by Impilo, through Impilo Investment Pool 2, since 2023.

When did Impilo acquire Decon?

Impilo acquired Decon in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue